Magnetically Powered Chitosan Milliwheels for Rapid Translation, Barrier Function Rescue, and Delivery of Therapeutic Proteins to the Inflamed Gut Epithelium.
Magnetically Powered Chitosan Milliwheels for Rapid Translation, Barrier Function Rescue, and Delivery of Therapeutic Proteins to the Inflamed Gut Epithelium.
复制标题
DOI:
10.1021/acsomega.3c00886
复制
发表时间:
2023-03-28
期刊:
影响因子:
4.1
通讯作者:
Neeves, Keith B.
中科院分区:
文献类型:
--
作者:
Osmond, Matthew J.;Korthals, Elizabeth;Zimmermann, Coy J.;Roth, Eric J.;Marr, David W. M.;Neeves, Keith B.
Inflammatory bowel disease (IBD) is mediated by an overexpression of tumor necrosis factor-α (TNF) by mononuclear cells in the intestinal mucosa. Intravenous delivery of neutralizing anti-TNF antibodies can cause systemic immunosuppression, and up to one-third of people are non-responsive to treatment. Oral delivery of anti-TNF could reduce adverse effects; however, it is hampered by antibody degradation in the harsh gut environment during transit and poor bioavailability. To overcome these shortcomings, we demonstrate magnetically powered hydrogel particles that roll along mucosal surfaces, provide protection from degradation, and sustain the local release of anti-TNF. Iron oxide particles are embedded into a cross-linked chitosan hydrogel and sieved to produce 100–200 μm particles called milliwheels (m-wheels). Once loaded with anti-TNF, these m-wheels release 10 to 80% of their payload over 1 week at a rate that depends on the cross-linking density and pH. A rotating magnetic field induces a torque on the m-wheels that results in rolling velocities greater than 500 μm/s on glass and mucus-secreting cells. The permeability of the TNF-challenged gut epithelial cell monolayers was rescued in the presence of anti-TNF carrying m-wheels, which both neutralized the TNF and created an impermeable patch over leaky cell junctions. With the ability to translate over mucosal surfaces at high speed, provide sustained release directly to the inflamed epithelium, and provide barrier rescue, m-wheels demonstrate a potential strategy to deliver therapeutic proteins for the treatment of IBD.
登录
查看更多内容
影响因子:
2.9
作者:
Erickson C;Stager M;Riederer M;Payne KA;Krebs M
通讯作者:
Krebs M
DOI:
10.1111/jth.15617
发表时间:
2022-03
期刊:
Journal of thrombosis and haemostasis : JTH
影响因子:
--
作者:
Disharoon D;Trewyn BG;Herson PS;Marr DWM;Neeves KB
通讯作者:
Neeves KB
影响因子:
16.6
作者:
Kirtane AR;Abouzid O;Minahan D;Bensel T;Hill AL;Selinger C;Bershteyn A;Craig M;Mo SS;Mazdiyasni H;Cleveland C;Rogner J;Lee YL;Booth L;Javid F;Wu SJ;Grant T;Bellinger AM;Nikolic B;Hayward A;Wood L;Eckhoff PA;Nowak MA;Langer R;Traverso G
通讯作者:
Traverso G
影响因子:
5.8
作者:
Gan, Quan;Wang, Tao
通讯作者:
Wang, Tao
影响因子:
8
作者:
Harris, M. Scott;Hartman, Deborah;Fox, Barbara S.
通讯作者:
Fox, Barbara S.